Back to top
more

Balchem (BCPC)

(Delayed Data from NSDQ)

$167.73 USD

167.73
91,917

+2.97 (1.80%)

Updated Aug 15, 2024 04:00 PM ET

After-Market: $167.84 +0.11 (0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (158 out of 251)

Industry: Chemical - Specialty

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for BCPC

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Balchem Corporation falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 64 67 103 85 66
Receivables 125 132 117 98 93
Notes Receivable 0 0 0 0 0
Inventories 110 120 91 71 84
Other Current Assets 15 18 11 13 12
Total Current Assets 314 336 322 267 255
Net Property & Equipment 276 271 238 228 217
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 970 983 619 651 668
Deposits & Other Assets 17 15 12 11 9
Total Assets 1,597 1,625 1,199 1,166 1,156
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 56 57 56 24 37
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 58 53 63 49 36
Income Taxes Payable 5 2 1 0 0
Other Current Liabilities 26 23 21 19 17
Total Current Liabilities 148 140 144 94 92
Mortgages 0 0 0 0 0
Deferred Taxes/Income 52 63 46 51 56
Convertible Debt 0 0 0 0 0
Long-Term Debt 326 467 122 174 256
Non-Current Capital Leases 2 2 2 0 0
Other Non-Current Liabilities 0 0 3 12 2
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 543 686 322 338 412
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 2 2 2 2 2
Capital Surplus 146 129 148 173 174
Retained Earnings 897 814 732 657 591
Other Equity 9 -7 -5 4 -6
Treasury Stock 0 0 0 8 18
Total Shareholder's Equity 1,054 938 877 828 744
Total Liabilities & Shareholder's Equity 1,597 1,625 1,199 1,166 1,156
Total Common Equity 1,054 938 877 828 744
Shares Outstanding 32.20 32.10 32.30 32.30 32.10
Book Value Per Share 32.73 29.23 27.15 25.64 23.17

Fiscal Year End for Balchem Corporation falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents 64 60 64 77 67
Receivables 123 140 125 129 125
Notes Receivable 0 0 0 0 0
Inventories 117 110 110 116 125
Other Current Assets 16 14 15 19 20
Total Current Assets 320 325 314 341 337
Net Property & Equipment 273 274 276 269 271
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 946 954 970 959 977
Deposits & Other Assets 18 17 17 16 16
Total Assets 1,575 1,589 1,597 1,603 1,619
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable 0 0 0 0 0
Accounts Payable 55 60 56 50 56
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 51 49 58 54 54
Income Taxes Payable 3 12 5 0 0
Other Current Liabilities 0 0 26 0 0
Total Current Liabilities 113 124 148 108 114
Mortgages 0 0 0 0 0
Deferred Taxes/Income 50 51 52 59 62
Convertible Debt 0 0 0 0 0
Long-Term Debt 284 319 326 396 421
Non-Current Capital Leases 2 2 2 2 2
Other Non-Current Liabilities 0 0 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 463 510 543 578 612
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 2 2 2 2 2
Capital Surplus 159 154 146 141 137
Retained Earnings 959 926 897 896 867
Other Equity -7 -4 9 -14 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 1,112 1,079 1,054 1,025 1,007
Total Liabilities & Shareholder's Equity 1,575 1,589 1,597 1,603 1,619
Total Common Equity 1,112 1,079 1,054 1,025 1,007
Shares Outstanding 32.40 32.40 32.20 32.20 32.20
Book Value Per Share 34.33 33.30 32.73 31.84 31.27